Related Experiment Video
Updated: Jun 13, 2026
06:29
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis
Ioannis Kourtzelis1, Maciej M Markiewski, Michael Doumas
1First Department of Internal Medicine Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Blood
|April 29, 2010
Summary
Complement activation during hemodialysis causes tissue factor expression in neutrophils, promoting thrombosis. Inhibiting complement may prevent blood clots in end-stage renal disease patients undergoing hemodialysis.
Area of Science:
- Nephrology
- Immunology
- Hematology
Background:
- Thrombosis is a frequent complication in end-stage renal disease (ESRD) patients on hemodialysis.
- Mechanisms underlying hemodialysis-associated thrombosis require further elucidation.
Purpose of the Study:
- To investigate the role of complement activation in hemodialysis-induced thrombosis.
- To explore the link between complement activation, tissue factor expression, and thrombosis in ESRD patients.
Main Methods:
- Assessed complement activation and its downstream effects in blood from hemodialysis patients.
- Measured tissue factor (TF) expression on neutrophils.
- Evaluated granulocyte colony-stimulating factor (G-CSF) induction.
- Investigated the impact of complement inhibition on TF and G-CSF levels.
Main Results:
- Hemodialysis biomaterials trigger complement activation, generating C5a.
- C5a induces functional tissue factor (TF) expression in peripheral blood neutrophils.
- Complement activation contributes to G-CSF induction, implicated in thrombosis.
- Inhibiting complement activation reduced TF expression and G-CSF induction.
Conclusions:
- Complement activation during hemodialysis is a key driver of thrombosis via TF induction.
- The complement system represents a potential therapeutic target for preventing thrombosis in hemodialysis patients.
- Targeting complement may mitigate thrombotic risks in chronic renal failure patients.
Related Concept Videos
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:25Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...